Product Images Clopidogrel

This appears to be a list of various medications used for the treatment of acid reflux and related conditions. The text mentions Dexlansoprazole, Lansoprazole, Pantoprazole, and Omeprazole, along with their respective dosages. The last line references an "active metabolite AUC" and "mean and 90% confidence interval," which suggest some sort of analysis of the drugs' effectiveness. However, without further context or clarification, it is not possible to determine the specific details or implications of this analysis.*

The text shows a table that displays the cumulative event rates, in percentages, for two treatments: placebo and clopidogrel with aspirin. The events being tracked are cardiovascular death, myocardial infarction, and stroke. The data is shown for 16 months and 12 months of follow-up. The table is labeled with a study identifier (P-000009) and a reference code (T2 5456 78 90N). The text mentions that other standard therapies were used as appropriate.*

This appears to be a chart or graph showing the Cumulative Event Rate (in percentage) for fatal or non-fatal vascular events over months of follow-up for two medications, aspirin and clopidogrel. No further information is available.*

This is a package insert for Clopidogrel medication indicating that each tablet contains 97,675 mg of copidogeel disulfate equivalent to 75 mg clopidogrel base. The medication is stored at a temperature range of 68-77 degrees Fahrenheit (120 - 25 degrees Celsius) and dispensed in a resistant container. The prescription drug is indicated in the treatment of patients with arterial thrombosis. Pharmacists are advised to dispense the medication using the provided medication guide.*

The text appears to be a description of a medication called Clopidogrel in the form of tablets. The tablets contain 391.5mg of Clopidogrel. The usual adult dosage is not mentioned. The tablets come in a light-resistant container and should be stored at a temperature between 20°C to 25°C. There is a controlled room guide provided for each patient. The text also mentions a package insert for 300 mg tablets. However, due to the poor quality of the , some parts of the text are not readable.*